Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Stock Buybacks and Dividends

Dividends would not attract investors to a speculative stock like PTSC. Building a strong viable company would attrack investors as they see PTSC with sustaining revenue and earnings.

Share
New Message
Please login to post a reply